Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English
  • Spanish

Education

Medical School

Mount Sinai School of Medicine

2008, New York, MA

Internship

Boston Children’s Hospital / Brigham and Women’s Hospital

2009, Boston, MA

Residency

Boston Children’s Hospital / Brigham and Women’s Hospital

2012, Boston, MA

Fellowship

Boston Children’s Hospital / Beth Israel Deaconess Medical Center

2016, Boston, MA

Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Rheumatology)

Professional History

I am a pediatric and adult rheumatologist at Boston Children’s Hospital and Beth Israel Deaconess Medical Center with an interest in autoinflammatory diseases, health-related technology, and medical education.

I graduated magna cum laude with a bachelor’s degree in Biology from Amherst College and attended medical school at Mount Sinai School of Medicine, graduating as the top student in my class.

I completed a combined residency in Internal Medicine and Pediatrics (Med-Peds) at Brigham and Women’s and Boston Children’s Hospital and then pursued a combined pediatric and adult rheumatology fellowship at Boston Children’s Hospital and Beth Israel Deaconess Medical Center. In 2014, I received the Distinguished Fellow award of the American College of Rheumatology.

While in fellowship, I helped to create Autoinflammatory Diseases Centers at Beth Israel Deaconess Medical Center and at Boston Children’s Hospital. I created Feverprints, an Apple ResearchKit app that recruits children and adults into a study to better understand temperatures in health and disease. I am also leading a study using wearable technology in patients with autoinflammatory diseases.

In 2014, I participated in the Rabkin Fellowship for Medical Education. I explored the use of cognitive learning theories and technology to improve medical education. I created AskUp, a free, open-source web app that leverages these techniques for student-generated questions. I am currently participating in the HMS Academy Fellowship in Medical Education Research, working to improve the types of questions used in the classroom and medical school exams.

Lastly, I am interested in the use of social media for medical education and personal development. I am exploring how adolescent patients use social media to obtain or share health information, and how physicians have adopted social media for personal and professional use. I have a personal blog (autoinflammatorydiseases.org) and I’m active on Twitter.

Publications

  1. Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2025 Mar 17. View Abstract

  2. Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry. Arthritis Care Res (Hoboken). 2024 02; 76(2):274-287. View Abstract

  3. Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand. Lancet Reg Health West Pac. 2023 Sep; 38:100843. View Abstract

  4. Update on autoinflammatory diseases. Curr Opin Rheumatol. 2023 09 01; 35(5):285-292. View Abstract

  5. Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2023 10; 75(10):2063-2072. View Abstract

  6. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome and Syndrome of Unexplained Recurrent Fevers in Children and Adults. J Allergy Clin Immunol Pract. 2023 06; 11(6):1676-1687. View Abstract

  7. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Ann Rheum Dis. 2023 05; 82(5):698-709. View Abstract

  8. Case 3-2023: A 16-Year-Old Girl with Abdominal Pain and Bloody Diarrhea. N Engl J Med. 2023 01 26; 388(4):358-368. View Abstract

  9. Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. Front Immunol. 2022; 13:1068399. View Abstract

  10. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance. Arthritis Care Res (Hoboken). 2023 01; 75(1):53-60. View Abstract

  11. Implementing a Virtual Flipped Classroom in a Rheumatology Fellowship Program. Arthritis Care Res (Hoboken). 2023 03; 75(3):634-639. View Abstract

  12. Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases. Eur J Rheumatol. 2022 Oct; 9(4):185-190. View Abstract

  13. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. RMD Open. 2022 09; 8(2). View Abstract

  14. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2022 09; 8(2). View Abstract

  15. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. ACR Open Rheumatol. 2022 Nov; 4(11):948-953. View Abstract

  16. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study. Lancet Rheumatol. 2022 Sep; 4(9):e603-e613. View Abstract

  17. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. ACR Open Rheumatol. 2022 Oct; 4(10):872-882. View Abstract

  18. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. J Rheumatol. 2022 Sep; 49(9):1042-1051. View Abstract

  19. Engaging trainees within the virtual classroom: Teaching strategies for rheumatologists in a pandemic. Eur J Rheumatol. 2022 07; 9(3):148-152. View Abstract

  20. Features predicting colchicine efficacy in treatment of children with undefined systemic autoinflammatory disease: A retrospective cohort study. Eur J Rheumatol. 2022 07; 9(3):116-121. View Abstract

  21. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology (Oxford). 2022 06 28; 61(SI2):SI143-SI150. View Abstract

  22. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Arthritis Rheumatol. 2022 07; 74(7):1102-1121. View Abstract

  23. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022 07; 81(7):907-921. View Abstract

  24. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. RMD Open. 2022 04; 8(1). View Abstract

  25. The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey. Rheumatol Adv Pract. 2022; 6(1):rkac001. View Abstract

  26. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2022 07; 81(7):970-978. View Abstract

  27. Feasibility and Efficacy of Online Strategies to Recruit Parents of Children With Rheumatic Diseases for Research. ACR Open Rheumatol. 2022 May; 4(5):410-416. View Abstract

  28. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Lancet Rheumatol. 2022 Apr; 4(4):e237-e240. View Abstract

  29. The Promises and Perils of Social Media for Pediatric Rheumatology. Rheum Dis Clin North Am. 2022 02; 48(1):233-243. View Abstract

  30. Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees. ACR Open Rheumatol. 2022 Feb; 4(2):128-133. View Abstract

  31. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. Lancet Rheumatol. 2021 Dec; 3(12):e855-e864. View Abstract

  32. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Netw Open. 2021 10 01; 4(10):e2129639. View Abstract

  33. Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI Insight. 2021 09 22; 6(18). View Abstract

  34. COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. J Rheumatol. 2022 01; 49(1):110-114. View Abstract

  35. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021 09; 7(3). View Abstract

  36. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021 Oct; 3(10):e707-e714. View Abstract

  37. Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children. Clin Exp Rheumatol. 2021 Sep-Oct; 39 Suppl 132(5):102-108. View Abstract

  38. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146. View Abstract

  39. Removing barriers and disparities in health: lessons from the COVID-19 pandemic. Nat Rev Rheumatol. 2021 03; 17(3):125-126. View Abstract

  40. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 03; 73(3):374-380. View Abstract

  41. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942. View Abstract

  42. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. Rheumatology (Oxford). 2021 01 05; 60(1):353-358. View Abstract

  43. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View Abstract

  44. Burden of illness in hereditary periodic fevers: a multinational observational patient diary study. Clin Exp Rheumatol. 2020 Sep-Oct; 38 Suppl 127(5):26-34. View Abstract

  45. Conducting research in a pandemic: The power of social media. Eur J Rheumatol. 2020 Aug; 7(Suppl 2):S85-S88. View Abstract

  46. Capturing Patient-Reported Outcomes During the COVID-19 Pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey. Arthritis Care Res (Hoboken). 2020 Jul; 72(7):871-873. View Abstract

  47. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology (Oxford). 2020 06 01; 59(6):1204-1206. View Abstract

  48. Adult-Onset Autoinflammatory Syndromes. J Clin Rheumatol. 2020 Jun; 26(4):160-163. View Abstract

  49. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866. View Abstract

  50. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020 May; 2(5):e250-e253. View Abstract

  51. Using Questions to Enhance Rheumatology Education. Arthritis Care Res (Hoboken). 2019 10; 71(10):1304-1309. View Abstract

  52. Using Smartphone Crowdsourcing to Redefine Normal and Febrile Temperatures in Adults: Results from the Feverprints Study. J Gen Intern Med. 2018 12; 33(12):2046-2047. View Abstract

  53. Adult-Onset Autoinflammatory Syndromes. J Clin Rheumatol. 2018 Nov 29. View Abstract

  54. Targeting cytokines to treat autoinflammatory diseases. Clin Immunol. 2019 09; 206:23-32. View Abstract

  55. The patient journey to diagnosis and treatment of autoinflammatory diseases. Orphanet J Rare Dis. 2018 09 06; 13(1):156. View Abstract

  56. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken). 2018 08; 70(8):1228-1237. View Abstract

  57. 2015 American College of Rheumatology Workforce Study: The Role of Graduate Medical Education in Adult Rheumatology. Arthritis Rheumatol. 2018 06; 70(6):817-825. View Abstract

  58. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015-2030. Arthritis Care Res (Hoboken). 2018 04; 70(4):617-626. View Abstract

  59. Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Rheumatol Int. 2017 Jun; 37(6):883-889. View Abstract

  60. Adolescent and Young Adult Use of Social Media for Health and Its Implications. J Adolesc Health. 2017 Jun; 60(6):714-719. View Abstract

  61. Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017 02 23; 2(4):e89703. View Abstract

  62. Evidence-based decision support for pediatric rheumatology reduces diagnostic errors. Pediatr Rheumatol Online J. 2016 Dec 13; 14(1):67. View Abstract

  63. Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. Arthritis Care Res (Hoboken). 2016 12; 68(12):1859-1865. View Abstract

  64. A piece of my mind. One stroke at a time. JAMA. 2014 Sep 03; 312(9):893-4. View Abstract

  65. Arthritis, fever, and weight loss in a teenager. The Rheumatologist. 2014; 1(8):39-41.

  66. Hypercalcemia and miliary sarcoidosis in a 15-year-old boy. Arthritis Rheum. 2013 Aug; 65(8):2112. View Abstract

  67. Autoinflammatory diseases in pediatrics. Dermatol Clin. 2013 Jul; 31(3):481-94. View Abstract

  68. Variation in total and specific IgE: effects of ethnicity and socioeconomic status. J Allergy Clin Immunol. 2005 Apr; 115(4):751-7. View Abstract

  69. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004 Oct; 31(10):1435-42. View Abstract

  70. Errors in medical interpretation: our concerns for public health and a call for caution. Pediatrics. 2003 Jun; 111(6 Pt 1):1495-7; author reply 1495-7. View Abstract

  71. T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc Natl Acad Sci U S A. 1999 Aug 17; 96(17):9769-74. View Abstract

  72. Altered ratio of collagen chains in bone of a patient with non-lethal osteogenesis imperfecta. Biochim Biophys Acta. 1992 Feb 14; 1138(2):93-6. View Abstract

  73. Glycosaminoglycan content in neonatal rat aortic smooth muscle cell cultures. Atherosclerosis. 1988 Jan; 69(1):61-8. View Abstract
BESbswy